THC, tetrahydrocannabinol, the substance responsible for the psychoactive effects for marijuana we associate with getting high, comes with side effects such as reduced short-term memory, impaired thinking and potential anxiety, while CBD, cannabidiol, possesses therapeutic effects such as relief of pain, stress, depression, Alzheimer’s, epilepsy, as well as protecting those parts of the brain associated with memory and learning. CBD's positive effects are due to its ability to bond with receptors in the brain, hence the anti-anxiety, anti-spasmodic and neuroprotective effects, as well as receptors throughout the body, lending itself to anti-inflammation and pain relief.
BioCBD plus products are made from the finest, organically grown industrial hemp and Ayurvedic herbs. Their hemp is grown in Northern Europe using sustainable farming practices. BioCBD Plus is focused on creating all-natural benefits of CBD with other popular herbs, including eucalyptus, burseraceae, ginger, curcumin, white willow bark, and BioAvailable CBD . By using only simple and natural ingredients, BioCBD Plus ensures that you know exactly what goes into your supplement and how it can benefit you.
The topical menthol ointment is our most common product for direct application to sore joints, muscle tissue, and damaged skin areas. Standard CBD oil drops can take up to an hour (or longer) to take effect (since they have to enter into the bloodstream), but with topical creams, effects are typically felt within minutes as the active cannabidiol simply has to diffuse across the dermal layers and to the site of inflammation.
Our CBD products and extracts are derived from hemp (not marijuana), and can also be referred to as CBD-rich hemp oil, hemp-derived CBD oil, CBD-rich cannabis oil, or plainly “hemp extracts,” since they typically contain more than just CBD. However, CBD oil is different from hemp seed oil and organic hemp oil, as these are derived from hemp seeds (not the resin) and do not contain cannabidiol.
^ Jump up to: a b Devinsky, Orrin; Cilio, Maria Roberta; Cross, Helen; Fernandez-Ruiz, Javier; French, Jacqueline; Hill, Charlotte; Katz, Russell; Di Marzo, Vincenzo; Jutras-Aswad, Didier; Notcutt, William George; Martinez-Orgado, Jose; Robson, Philip J.; Rohrback, Brian G.; Thiele, Elizabeth; Whalley, Benjamin; Friedman, Daniel (22 May 2014). "Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders". Epilepsia. 55 (6): 791–802. doi:10.1111/epi.12631. PMC 4707667. PMID 24854329.